-- Egis Sees Sales Rising as Much as 6% Next Year, MTI Reports
-- B y   E d i t h   B a l a z s
-- 2012-08-07T09:53:58Z
-- http://www.bloomberg.com/news/2012-08-07/egis-sees-sales-rising-as-much-as-6-next-year-mti-reports.html
Egis (EGIS)  Nyrt., the Hungarian drugmaker
owned by Laboratoires Servier, expects revenue growth to pick up
next year on accelerating exports, state news service  MTI  said,
citing Chief Financial Officer Csaba Poroszlai.  Total  revenue  probably will increase between 4 percent and
6 percent next year in forint terms after a projected sales
growth of between 3 percent to 5 percent this year, Poroszlai
said, according to MTI.  Domestic sales are expected to drop as much as 10 percent
in the 2012/2013 fiscal year, while exports to the  Commonwealth
of Independent States  are set to grow between 8 percent and 12
percent, similarly to Russian sales, Poroszlai said, MTI
reported.  To contact the reporter on this story:
Edith Balazs in Budapest at 
 ebalazs1@bloomberg.net   To contact the editor responsible for this story:
James M. Gomez at 
 jagomez@bloomberg.net  